Michael J. Sofia's most recent trade in Arbutus Biopharma Corp was a trade of 437,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | Michael J. Sofia | Chief Scientific Officer | 01 Feb 2024 | 437,800 | 437,800 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | Sofia Michael J. | Chief Scientific Officer | 01 Feb 2024 | 109,500 | 1,495,103 (2%) | 0% | 0 | Common Shares | ||
| Arbutus Biopharma Corp | J. Sofia Michael | Chief Scientific Officer | 01 Feb 2024 | 9,982 | 1,485,121 (2%) | 0% | 2.3 | 23,083 | Common Shares | |
| Arbutus Biopharma Corp | Michael J. Sofia | Chief Scientific Officer | 01 Feb 2023 | 328,700 | 328,700 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | Michael J. Sofia | Chief Scientific Officer | 01 Feb 2023 | 82,200 | 1,385,603 (2%) | 0% | 0 | Common Shares | ||
| Arbutus Biopharma Corp | Michael J. Sofia | Chief Scientific Officer | 20 Jan 2022 | 285,000 | 285,000 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | Michael J. Sofia | Chief Scientific Officer | 13 Feb 2021 | 290,000 | 290,000 | - | - | Stock Options |